JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF – Get Free Report) was the recipient of a significant decline in short interest in the month of August. As of August 31st, there was short interest totaling 238,313 shares, a decline of 48.0% from the August 15th total of 457,885 shares. Based on an average daily volume of 27 shares, the days-to-cover ratio is currently 8,826.4 days.
JCR Pharmaceuticals Price Performance
Shares of JCRRF stock opened at $3.33 on Tuesday. The firm has a fifty day moving average of $3.32 and a 200-day moving average of $3.69. JCR Pharmaceuticals has a 12-month low of $3.15 and a 12-month high of $3.33.
About JCR Pharmaceuticals
JCR Pharmaceuticals Co, Ltd. is a Japan-based biotechnology company specializing in the development, production and commercialization of plasma-derived products and regenerative medicine solutions. The company focuses on manufacturing high-purity plasma proteins, including human serum albumin, immunoglobulins and coagulation factors, to support a range of therapeutic applications in hematology, immunology and critical care settings.
In its plasma-derived business, JCR leverages state-of-the-art fractionation and purification processes to supply products such as intravenous immunoglobulin and albumin formulations.
See Also
- Five stocks we like better than JCR Pharmaceuticals
- Navan’s Strong Quarter Meets an AI Spending Reality Check
- LightPath’s Defense Pivot Could Send Shares Higher
- Clearance to Climb: Why Allegiant Has Room to Fly
- 3 Defense Stocks Riding the High-Energy Laser Boom
Receive News & Ratings for JCR Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JCR Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
